EAST RUTHERFORD, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Cambrex
Corporation (NYSE: CBM) announces that Gary L. Mossman, Executive Vice
President, Chief Operating Officer and President Cambrex Pharma, will
retire effective August 31, 2006. Upon Mr. Mossman's retirement, Steven M.
Klosk, Executive Vice President and Chief Operating Officer -- Biopharma
will assume responsibility for the Pharma business. Paulo Russolo,
President -- Cambrex Profarmaco, Shawn Cavanagh, Sr. Vice President and
General Manager -- Bioproducts and Steven M. Klosk, Executive Vice
President and Chief Operating Officer -- Biopharma & Pharma will report
directly to James A. Mack, Chairman, President and Chief Executive Officer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )
Mr. Mack commented, "We were fortunate to have had Gary's experience
and leadership over the last 3 1/2 years and he leaves the business
extraordinarily well positioned for continued success in the years to come.
We wish him all the best in his retirement."
About Cambrex
Cambrex is a global, diversified life sciences company dedicated to
providing products and services to accelerate and improve the discovery and
commercialization of human therapeutics. The Company employs approximately
2,000 worldwide. For more information, please visit http://www.cambrex.com.
SOURCE Cambrex
 back to top
Related links:
http://www.cambrex.com/
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO
http://www.prnewswire.com/comp/134219.html /
CONTACT:
Anne-Marie Hess, Sr. Director, Investor
Relations & Corporate Communications, of Cambrex,
+1-201-804-3062, or annemarie.hess@cambrex.com
|
